Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (600671.SS)
CNY 9.33
(0.0%)
CNY 9.33
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 346.28 Million CNY | 15.49% |
| 2022 | 299.83 Million CNY | -25.53% |
| 2021 | 402.64 Million CNY | -9.01% |
| 2020 | 442.51 Million CNY | -16.02% |
| 2019 | 526.92 Million CNY | 9.64% |
| 2018 | 480.61 Million CNY | 6.7% |
| 2017 | 450.44 Million CNY | 47.11% |
| 2016 | 306.19 Million CNY | 9.21% |
| 2015 | 280.38 Million CNY | -1.84% |
| 2014 | 285.64 Million CNY | -12.18% |
| 2013 | 325.26 Million CNY | 9.92% |
| 2012 | 295.92 Million CNY | -17.3% |
| 2011 | 357.83 Million CNY | 11.9% |
| 2010 | 319.79 Million CNY | -2.58% |
| 2009 | 328.27 Million CNY | -11.06% |
| 2008 | 369.08 Million CNY | -10.87% |
| 2007 | 414.08 Million CNY | 17.48% |
| 2006 | 352.47 Million CNY | -5.43% |
| 2005 | 372.7 Million CNY | 4.15% |
| 2004 | 357.85 Million CNY | 3.27% |
| 2003 | 346.51 Million CNY | -7.23% |
| 2002 | 373.52 Million CNY | -8.62% |
| 2001 | 408.74 Million CNY | 0.71% |
| 2000 | 405.88 Million CNY | 19.45% |
| 1999 | 339.77 Million CNY | 5.19% |
| 1998 | 323.01 Million CNY | 9.24% |
| 1997 | 295.68 Million CNY | 14.02% |
| 1996 | 259.33 Million CNY | -1.4% |
| 1995 | 263.02 Million CNY | 36.9% |
| 1994 | 192.12 Million CNY | 69.27% |
| 1993 | 113.49 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 366.35 Million CNY | 9.97% |
| 2024 Q2 | 333.14 Million CNY | 6.55% |
| 2024 Q1 | 312.67 Million CNY | -9.71% |
| 2023 Q4 | 346.28 Million CNY | 1.72% |
| 2023 Q1 | 284.2 Million CNY | -5.21% |
| 2023 Q2 | 256.6 Million CNY | -9.71% |
| 2023 FY | 346.28 Million CNY | 15.49% |
| 2023 Q3 | 340.44 Million CNY | 32.67% |
| 2022 Q4 | 299.83 Million CNY | -14.07% |
| 2022 FY | 299.83 Million CNY | -25.53% |
| 2022 Q1 | 390.94 Million CNY | -2.91% |
| 2022 Q2 | 373.43 Million CNY | -4.48% |
| 2022 Q3 | 348.93 Million CNY | -6.56% |
| 2021 Q4 | 402.64 Million CNY | -3.88% |
| 2021 Q1 | 440.79 Million CNY | -0.39% |
| 2021 FY | 402.64 Million CNY | -9.01% |
| 2021 Q2 | 431.14 Million CNY | -2.19% |
| 2021 Q3 | 418.88 Million CNY | -2.84% |
| 2020 FY | 442.51 Million CNY | -16.02% |
| 2020 Q1 | 525.13 Million CNY | -0.34% |
| 2020 Q2 | 523.76 Million CNY | -0.26% |
| 2020 Q3 | 518.98 Million CNY | -0.91% |
| 2020 Q4 | 442.51 Million CNY | -14.74% |
| 2019 Q1 | 479.18 Million CNY | -0.3% |
| 2019 Q4 | 526.92 Million CNY | 0.23% |
| 2019 FY | 526.92 Million CNY | 9.64% |
| 2019 Q3 | 525.72 Million CNY | 0.19% |
| 2019 Q2 | 524.75 Million CNY | 9.51% |
| 2018 Q2 | 447.95 Million CNY | -10.61% |
| 2018 Q1 | 501.1 Million CNY | 11.25% |
| 2018 Q4 | 480.61 Million CNY | 5.06% |
| 2018 FY | 480.61 Million CNY | 6.7% |
| 2018 Q3 | 457.44 Million CNY | 2.12% |
| 2017 Q2 | 293.48 Million CNY | 3.29% |
| 2017 Q4 | 450.44 Million CNY | 39.7% |
| 2017 FY | 450.44 Million CNY | 47.11% |
| 2017 Q1 | 284.13 Million CNY | -7.2% |
| 2017 Q3 | 322.42 Million CNY | 9.86% |
| 2016 Q1 | 302.07 Million CNY | 7.74% |
| 2016 Q2 | 286.23 Million CNY | -5.24% |
| 2016 Q4 | 306.19 Million CNY | 2.99% |
| 2016 Q3 | 297.3 Million CNY | 3.87% |
| 2016 FY | 306.19 Million CNY | 9.21% |
| 2015 FY | 280.38 Million CNY | -1.84% |
| 2015 Q2 | 268.97 Million CNY | -2.95% |
| 2015 Q3 | 267.02 Million CNY | -0.73% |
| 2015 Q4 | 280.38 Million CNY | 5.0% |
| 2015 Q1 | 277.14 Million CNY | -2.98% |
| 2014 Q1 | 300.13 Million CNY | -7.73% |
| 2014 Q2 | 331.87 Million CNY | 10.57% |
| 2014 Q3 | 289.71 Million CNY | -12.7% |
| 2014 FY | 285.64 Million CNY | -12.18% |
| 2014 Q4 | 285.64 Million CNY | -1.4% |
| 2013 Q3 | 324.88 Million CNY | 0.45% |
| 2013 Q4 | 325.26 Million CNY | 0.12% |
| 2013 FY | 325.26 Million CNY | 9.92% |
| 2013 Q1 | 311.65 Million CNY | 5.32% |
| 2013 Q2 | 323.44 Million CNY | 3.78% |
| 2012 FY | 295.92 Million CNY | -17.3% |
| 2012 Q1 | 335.34 Million CNY | -6.29% |
| 2012 Q4 | 295.92 Million CNY | -11.9% |
| 2012 Q2 | 332.96 Million CNY | -0.71% |
| 2012 Q3 | 335.89 Million CNY | 0.88% |
| 2011 FY | 357.83 Million CNY | 11.9% |
| 2011 Q3 | 298.73 Million CNY | -3.97% |
| 2011 Q2 | 311.09 Million CNY | -3.02% |
| 2011 Q4 | 357.83 Million CNY | 19.78% |
| 2011 Q1 | 320.77 Million CNY | 0.31% |
| 2010 FY | 319.79 Million CNY | -2.58% |
| 2010 Q2 | 313.2 Million CNY | 0.78% |
| 2010 Q3 | 307.42 Million CNY | -1.84% |
| 2010 Q4 | 319.79 Million CNY | 4.02% |
| 2010 Q1 | 310.76 Million CNY | -5.33% |
| 2009 Q2 | 329.46 Million CNY | -8.54% |
| 2009 Q3 | 315.36 Million CNY | -4.28% |
| 2009 Q4 | 328.27 Million CNY | 4.09% |
| 2009 FY | 328.27 Million CNY | -11.06% |
| 2009 Q1 | 360.21 Million CNY | -2.4% |
| 2008 Q3 | 401.89 Million CNY | -1.23% |
| 2008 Q1 | 439.14 Million CNY | 6.05% |
| 2008 Q4 | 369.08 Million CNY | -8.17% |
| 2008 FY | 369.08 Million CNY | -10.87% |
| 2008 Q2 | 406.9 Million CNY | -7.34% |
| 2007 Q4 | 414.08 Million CNY | -5.48% |
| 2007 Q3 | 438.08 Million CNY | 10.77% |
| 2007 FY | 414.08 Million CNY | 17.48% |
| 2007 Q2 | 395.49 Million CNY | 2.31% |
| 2007 Q1 | 386.58 Million CNY | 9.68% |
| 2006 Q3 | 372.25 Million CNY | 2.88% |
| 2006 Q1 | 365.9 Million CNY | -1.83% |
| 2006 Q4 | 352.47 Million CNY | -5.31% |
| 2006 FY | 352.47 Million CNY | -5.43% |
| 2006 Q2 | 361.82 Million CNY | -1.11% |
| 2005 Q4 | 372.7 Million CNY | 6.46% |
| 2005 FY | 372.7 Million CNY | 4.15% |
| 2005 Q3 | 350.08 Million CNY | -5.44% |
| 2005 Q2 | 370.23 Million CNY | 0.12% |
| 2005 Q1 | 369.78 Million CNY | 3.34% |
| 2004 Q1 | 361.55 Million CNY | 4.34% |
| 2004 Q2 | 354.19 Million CNY | -2.04% |
| 2004 Q3 | 343.98 Million CNY | -2.88% |
| 2004 FY | 357.85 Million CNY | 3.27% |
| 2004 Q4 | 357.85 Million CNY | 4.03% |
| 2003 Q4 | 346.51 Million CNY | -3.34% |
| 2003 Q1 | 388.44 Million CNY | 3.99% |
| 2003 Q3 | 358.47 Million CNY | -4.5% |
| 2003 Q2 | 375.37 Million CNY | -3.37% |
| 2003 FY | 346.51 Million CNY | -7.23% |
| 2002 FY | 373.52 Million CNY | -8.62% |
| 2002 Q3 | 378.17 Million CNY | -10.16% |
| 2002 Q2 | 420.95 Million CNY | 2.06% |
| 2002 Q1 | 412.44 Million CNY | 0.91% |
| 2002 Q4 | 373.52 Million CNY | -1.23% |
| 2001 Q4 | 408.74 Million CNY | 0.0% |
| 2001 Q2 | 373 Million CNY | 0.0% |
| 2001 FY | 408.74 Million CNY | 0.71% |
| 2000 Q4 | 405.88 Million CNY | 0.0% |
| 2000 FY | 405.88 Million CNY | 19.45% |
| 2000 Q2 | 403.86 Million CNY | 0.0% |
| 1999 FY | 339.77 Million CNY | 5.19% |
| 1999 Q2 | 335.24 Million CNY | 0.0% |
| 1999 Q4 | 339.77 Million CNY | 0.0% |
| 1998 FY | 323.01 Million CNY | 9.24% |
| 1998 Q4 | 323.01 Million CNY | 0.0% |
| 1998 Q2 | 316.3 Million CNY | 0.0% |
| 1997 Q4 | 295.68 Million CNY | 0.0% |
| 1997 Q2 | 263.58 Million CNY | 0.0% |
| 1997 FY | 295.68 Million CNY | 14.02% |
| 1996 FY | 259.33 Million CNY | -1.4% |
| 1996 Q4 | 259.33 Million CNY | 0.0% |
| 1996 Q2 | 284.29 Million CNY | 0.0% |
| 1995 FY | 263.02 Million CNY | 36.9% |
| 1995 Q4 | 263.02 Million CNY | 0.0% |
| 1995 Q2 | 187.12 Million CNY | 0.0% |
| 1994 FY | 192.12 Million CNY | 69.27% |
| 1994 Q2 | 157.91 Million CNY | 0.0% |
| 1994 Q4 | 192.12 Million CNY | 0.0% |
| 1993 FY | 113.49 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 43.78 Billion CNY | 99.209% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 17.08 Billion CNY | 97.973% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 11.23 Billion CNY | 96.919% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 3.27 Billion CNY | 89.44% |
| Aurora Optoelectronics Co.,Ltd. | 2.17 Billion CNY | 84.071% |
| NanJing Pharmaceutical Company Limited | 28.5 Billion CNY | 98.785% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 2.62 Billion CNY | 86.825% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 7.77 Billion CNY | 95.544% |